52 results found.
      
BARE BONES® - July 7, 2014
aap Implantate posted preliminary 2Q14 sales of €8.0MM (~US $10.8MM), +23% from 2Q13. (Trauma/LOQTEQ ~$4MM, +7%: LOQTEQ standalone ~$2.6MM, +19%; Biomaterials ~$6.6MM, +50%
1Q14 Revenue: aap Implantate
€6.1MM (~US $8.4MM), +33% Trauma/LOQTEQ ~$3MM, +47% (LOQTEQ ~$1.5MM, +175%) Biomaterials ~$5.3MM, +25% Results exclude divestiture of EMCM. Strong growth in Bulgaria, Czech Republic, Italy, Spain, Turkey, Russia
BARE BONES® - March 31, 2014
aap Implantate posted 2013 product sales of €40MM (~US $55.1MM), +10% from 2012, with Trauma revenue of ~$13.2MM, +52% (LOQTEQ ~$6.8MM). (
4Q13/2013 Revenue: aap Implantate
2013 revenue:  €40MM (~US $55.1MM), +10% Trauma ~$13.2MM, +52% (LOQTEQ ~$6.8MM, +150%)   Signed development/supply agreement for PMMA bone cement & mixing system In early 2014, divested non-core Adcon ant...
BARE BONES® - November 11, 2013
aap Implantate posted 3Q13 revenue of €8.8MM (~US $11.7MM), +2% from 3Q12. (Trauma ~US $3MM, +50%) (
3Q13 Revenue: aap Implantate
€8.8MM (~US $11.7MM), +2% Trauma ~$3MM, +50% LOQTEQ ~$1.5MM, +83% Trauma growth driven by SMIT (South Korea, Mexico, Indonesia, Turkey) and BRIC (Brazil, Russia, India, China) Signed new LOQTEQ distribution agreement with Sa...
BARE BONES® - October 8, 2013
aap Implantate posted preliminary 3Q13 revenue of €8.8MM (~US $11.94MM), +2% from 3Q12, with Trauma sales of ~$3.1MM, +53%. (
BARE BONES® - August 14, 2013
aap Implantate reported 2Q13 sales of €9.2MM (~US $12.2MM), +1% from 2Q12. (Trauma ~$3.7MM, +155%) (
2Q13 Revenue: aap Implantate
€9.2MM (~US $12.2MM), +1% (Trauma ~$3.7MM, +155%) OEM sales of bone cement/cementing techniques down slightly, offset by strong LOQTEQ and biomaterials sales Divested non-core recon products (hip, knee, shoulder)  
BARE BONES® - July 9, 2013
aap Implantate reported preliminary 1H13 revenue of €19.5MM (~US $25MM), +3% from 1H12, and 2Q13 estimated revenue of ~$11.8MM, +2% from 2Q12. (1H13 Trauma/LOQTEQ
BARE BONES® - May 15, 2013
aap Implantate posted 1Q13 sales of €10.4MM (~US $13.4MM), +5% from 1Q12. (Trauma ~$1.94MM, +15%: LOQTEQ ~$0.5MM, +300%) (
1Q13 Revenue: aap Implantate
€10.4MM (~US $13.4MM), +5% (Trauma ~$1.94MM, +15%: LOQTEQ ~$0.5MM, +300%) Entered a multi-year supply and development agreement for certain biomaterial products Entered into a joint venture to co-develop resorbable magnesium trauma products with Eontec
4Q12 and 2012 Revenue: aap Implantate
AAP IMPLANTATE  €36.4MM (~US $47.9MM), +25%  - LOQTEQ €2.0 (~US $2.6MM) - Signed pilot U.S. marketing agreement in 4Q for LOQTEQ plates - Signed agreement to co-develop bone cement with unnamed global me...
BARE BONES® - March 28, 2013
aap Implantate affirmed its 2012 product sales of €36.4MM (~US $47.9MM), +25% from 2011. (aap Implantate AG, 3/28/13)
BARE BONES® - January 7, 2013
aap Implantate posted preliminary 4Q12 revenue of €8.9MM (US $11.7MM), +9% from 4Q11, and 2012 preliminary revenue of €36.4MM ($47.9MM), +25% from 2011. (
BARE BONES® - November 12, 2012
aap Implantate posted 3Q12 revenue of €8.6MM (~US $10.9MM), +25% from 3Q11. (aap Implantate AG, 11/12/1...
3Q12 Earnings: aap Implantate
€8.6MM (~US $10.9MM), +25% (Trauma +46%; Biomaterials +7%; Gels/Fluids/Bone Material Contract Manufacture +>100%) Received FDA clearance for LOQTEQ plating systems, expecting clearance of entire product family in 4Q Developing 6 additional LOQTEQ systems...
BARE BONES® - October 1, 2012
aap Implantate announced preliminary 3Q12 revenue of €8.6MM (~US $11.1MM), +25% from 3Q11. Growth was primarily driven by LOQTEQ® and biomaterial product sales. (
Final 2Q12 Results
ORTHOWORLD’s estimates place 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted.  Exhibit 1 Ort...
BARE BONES® - August 14, 2012
aap Implantate reported 2Q12 sales of €9.0MM (~US $11.1MM), +18% from 2Q11. (aap Implantate AG, 8/14/12)
Final 1Q12 Results
ORTHOWORLD’s estimates place overall 1Q12 market growth at 4% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increas...
BARE BONES® - May 15, 2012
aap Implantate posted 1Q12 sales of €9.9MM (~US $12.7MM), +51% from 1Q11, with product sales ~$9.8MM, +18%. (
BARE BONES® - March 30, 2012
 aap Implantate posted 2011 product sales of €29.2MM (~US $38.9MM), +6% from 2010. (aap Implantate AG , 3/30/12)
3Q11: A First Look at Financials: aap Implantate
AAP IMPLANTATE €6.9MM (~US $9.4MM), -4% * Commenced international launch of LOQTEQ trauma products * Signed 2 new contracts for biomaterials with customers in Brazil and Israel
Final 2Q11 Results: aap Implantate
AAP IMPLANTATE €7.6MM (~US $10.9MM), +9% * Launched WSG trauma product in Germany; filing for FDA clearance in 4Q11 * Commenced delivery of antibiotic-laden collagen fleece * Signed agreement for U.S. distribution of cannulated screws
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group